Pharmacological and clinical studies of the antiandrogen Anandron
- 31 December 1987
- journal article
- review article
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 27 (4-6) , 871-875
- https://doi.org/10.1016/0022-4731(87)90162-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancerJournal of Steroid Biochemistry, 1986
- Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.BMJ, 1985
- Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostateUrology, 1985
- Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.BMJ, 1984
- Continuous subcutaneous administration of ‘Zoladex’ (ICI 118,630 — an LH-RH analogue) to patients with advanced prostatic cancerJournal of Steroid Biochemistry, 1984
- The in Vivo Glucocorticoid and Antiglucocorticoid Actions of Medroxyprogesterone AcetateEndocrinology, 1980
- Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissuesJournal of Steroid Biochemistry, 1979
- Steroid levels in cancer of the prostate-markers of tumour differentiation and adequacy of anti-androgen therapyJournal of Steroid Biochemistry, 1979
- An in vivo study of the action of antiglucocorticoids on thymus weight ratio, antibody titre and the adrenal-pituitary-hypothalamus axisThe Journal of Steroid Biochemistry and Molecular Biology, 1979
- Pharmacology and Potential Use of Cyproterone AcetateHormone and Metabolic Research, 1977